TG Therapeutics (NASDAQ: TGTX) Ublituximab Receives Fast Track Designation In US
Hasnain R
October 21, 2020
TG Therapeutics, Inc. (NASDAQ: TGTX) has announced Wednesday that it has received the Fast Track Designation for its ublituximab/umbralisib combo for the treatment of adult